25002.pdf (2.06 MB)
0/0

Utilizing the folate receptor for active targeting of cancer nanotherapeutics

Download (2.06 MB)
journal contribution
posted on 06.12.2013 by Grant L. Zwicke, G. Ali Mansoori, Constance J. Jeffery
The development of specialized nanoparticles for use in the detection and treatment of cancer is increasing. Methods are being proposed and tested that could target treatments more directly to cancer cells, which could lead to higher efficacy and reduced toxicity, possibly even eliminating the adverse effects of damage to the immune system and the loss of quick replicating cells. In this mini-review we focus on recent studies that employ folate nanoconjugates to target the folate receptor. Folate receptors are highly overexpressed on the surface of many tumor types. This expression can be exploited to target imaging molecules and therapeutic compounds directly to cancerous tissues.

History

Publisher Statement

© 2012 Grant L. Zwicke et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The original version is available through Co-Action Publishing at DOI: 10.3402/nano.v3i0.18496.

Citation

Zwicke GL, Mansoori GA, Jeffery CJ. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano reviews. 2012;3. doi: 10.3402/nano.v3i0.18496.

Publisher

Co-Action Publishing

Language

en_US

issn

2000-5121

Issue date

01/12/2012

Exports

Categories

Exports